52 North Health
Medtech startup which has developed a device that allows patients to monitor themselves for potentially life-threatening side effects of chemotherapy
Cambridge, UKwww.52north.health ↗
Total raised
€2.6M
€2,583,362
Funding rounds
2
Investors
7
distinct backers
Active since
2022-04
latest 2022-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 46% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-23 | Grant | €1.4M | Innovate UK | View deal → |
| 2022-04-28 | Other | €1.2M | Angel Investors,Cambridge Enterprise,Crista Galli Ventures,King’s Health Partners MedTech Innovations,Meltwind,Milltrust Ventures | View deal → |
Investors
7Related news
- Medtech startup 52 North Health scales up its mission to improve chemotherapy treatmentseu-startups.com · 2022-11
- 52 North Health gets £1 million shot to boost affordable cancer caretech.eu · 2022-04
- Cambridge medtech founded by husband-wife duo picks £1M to monitor cancer chemotherapy riskstechfundingnews.com · 2022-04